Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. Abstract Text:

Anders M ,Leif Thuesen,Henning Kelbaek,Per Thayssen,Klaus Rasmussen,Peter R Hansen,Niels Bligaard,Kari ,Anders Junker,Jens ,Ulrik Abildgaard,Jan Ravkilde,Thomas ,Jan S Jensen,Henning R Andersen,Hans E , Galatius,Steen D Kristensen,Jan K Madsen,Lars R Krusell,Steen Z ,Ghita B Stephansen,Jens F Lassen, ,Anders M Galløe,Leif Thuesen,Henning Kelbaek,Per Thayssen,Klaus Rasmussen,Peter R Hansen,Niels Bligaard,Kari Saunamäki,Anders Junker,Jens Aarøe,Ulrik Abildgaard,Jan Ravkilde,Thomas Engstrøm,Jan S Jensen,Henning R Andersen,Hans E Bøtker,Søren Galatius,Steen D Kristensen,Jan K Madsen,Lars R Krusell,Steen Z Abildstrøm,Ghita B Stephansen,Jens F Lassen, ,

CONTEXT: Approval of drug-eluting coronary stents was based on results of relatively small trials of selected patients; however, in routine practice, stents are used in a broader spectrum of patients. OBJECTIVE: To compare the first 2 commercially available drug-eluting stents-sirolimus-eluting and paclitaxel-eluting-for prevention of symptom-driven clinical end points, using a study design reflecting everyday clinical practice. DESIGN, SETTING, AND PATIENTS: Randomized, blinded trial conducted August 2004 to January 2006 at 5 university hospitals in Denmark. Patients were 2098 men and women (mean [SD] age, 63.6 [10.8] years) treated with percutaneous coronary intervention (PCI) and randomized to receive either sirolimus-eluting (n = 1065) or paclitaxel-eluting (n = 1033) stents. Indications for PCI included ST-segment elevation myocardial infarction (STEMI), non-STEMI or unstable angina pectoris, and stable angina. MAIN OUTCOME MEASURES: The primary end point was a composite clinical end point of major adverse cardiac events, defined as either cardiac death, acute myocardial infarction, target lesion revascularization, or target vessel revascularization. Secondary end points included individual components of the composite end point, all-cause mortality, and stent thrombosis. RESULTS: The sirolimus- and the paclitaxel-eluting stent groups did not differ significantly in major adverse cardiac events (98 [9.3%] vs 114 [11.2%]; hazard ratio, 0.83 [95% confidence interval, 0.63-1.08]; P = .16) or in any of the secondary end points. The stent thrombosis rates were 27 (2.5%) and 30 (2.9%) (hazard ratio, 0.87 [95% confidence interval, 0.52-1.46]; P = .60), respectively. CONCLUSION: In this practical randomized trial, there were no significant differences in clinical outcomes between patients receiving sirolimus- and paclitaxel-eluting stents. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00388934.

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. Publishing Authors By Initials

AM ,L Thuesen,H Kelbaek,P Thayssen,K Rasmussen,PR Hansen,N Bligaard,K ,A Junker,J ,U Abildgaard,J Ravkilde,T ,JS Jensen,HR Andersen,HE ,S Galatius,SD Kristensen,JK Madsen,LR Krusell,SZ ,GB Stephansen,JF Lassen, ,AM Galløe,L Thuesen,H Kelbaek,P Thayssen,K Rasmussen,PR Hansen,N Bligaard,K Saunamäki,A Junker,J Aarøe,U Abildgaard,J Ravkilde,T Engstrøm,JS Jensen,HR Andersen,HE Bøtker,S Galatius,SD Kristensen,JK Madsen,LR Krusell,SZ Abildstrøm,GB Stephansen,JF Lassen, ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: JAMA : the journal of the American Medical Associa

VOLUME: 299

Page Numbers: 409-16

Journal Abbreviation: JAMA

ISSN: 1538-3598

DAY: 30

MONTH: Jan

YEAR: 2008

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7501160

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.

AFFILIATION: Department of Cardiology, Gentofte University Hospital, Hellerup, Copenhagen, Denmark. anders@galloe.dk

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: JAMA

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial Related Publications

• 123I-iomazenil as a clinical tool for studying neuronal loss.
• A clinical method for determination of regional lung function using intravenous injection of Xe133.
• A preliminary report on the 1952 epidemic of poliomyelitis in Copenhagen with special reference to the treatment of acute respiratory insufficiency.
• Bacterial adhesiveness and invasiveness in cell culture monolayer.
• Bacterial adhesiveness and invasiveness in cell culture monolayer. 2. In vitro invasiveness of 45 strains belonging to the family Enterobacteriaceae.
• Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
• Dermatologic radiotherapy and thyroid cancer. Dose measurements and risk quantification.
• Evidence of active transport (filtration?) of plasma proteins across the capillary walls in muscle and subcutis.
• Induced hypertension as a therapy in Buerger's disease (thromboangitis obliterans).
• Introduction to the development of paroxetine, a novel antidepressant.
• Long-term anticoagulant therapy in apoplexy.
• Mechanical ventilation for acute respiratory failure in diffuse chronic lung disease.
• Paralytic human rabies in Greenland.
• Rapid identification of gram-negative rods using a three-tube method combined with a dichotomic key.
• Raynaud's phenomenon: peripheral catecholamine concentration and effect of sympathectomy.
• Reabsorption of electrolytes and water from blood in the alimentary tract.
• Regional cerebral blood flow in cerebrovascular disease by SPECT (single photon emission computerized tomography).
• Sinonasal undifferentiated carcinoma: current trends in treatment.
• The management of respiratory and bulbar paralysis in poliomyelitis.
• Treatment delays in ST elevation myocardial infarction.
• Tuberculin reactor rate and B.C.G. vaccination in an Algerian rural area.
• [Lesions of the extremities.]
• [Not Available.]
• [Not Available.]
• [Reports on military surgery. V. Lesions of the extremities.]
• [Reports on military surgery. VII. War of peripheral nerves.]
• [War injuries of peripheral arteries.]
• [War injuries of the abdomen.]
• [War injuries of the abdomen.]
• [War injuries of the abdomen.]